Emergence Therapeutics

Description: Emergence Therapeutics develops novel antibody-drug conjugates (ADCs) to treat high-need cancers, focusing on Nectin-4 and other targets.

Country: Germany

Based in: Duisburg

Founded: 2019

Funding Stage: Series A/B

Tags: ['Fitness', 'Health Care', 'Wellness']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.